Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Linda Kaplan who wrote (5079)	8/4/1998 8:44:00 AM
From: Hank	Read Replies (1) \| Respond to of 7041

No sign of money flow into ZONA yet according to my data. RADAF is expected to earn around $2.50 this year. I think it could be as high as $3.00 If you assign a modest P/E of 10 for them, that puts the price at 24-30 by years end. Not unreasonable to expect IMHO. I also think they are a future take over candidate. Vector Vest has them valued at around $35, so they are grossly underpriced at these levels. Unless we slip into a total bear market, I should do well.